Status:
RECRUITING
Therapeutic Recommendations for Nephroblastoma
Lead Sponsor:
French Africa Pediatric Oncology Group
Conditions:
Nephroblastoma
Eligibility:
All Genders
6-18 years
Brief Summary
The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.
Detailed Description
The study is based on results form 2 previous studies carried out by the GFAOP. This study aims to evaluate the capacity of units to follow the recommendations in the protocol. It will look mainly at ...
Eligibility Criteria
Inclusion
- Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment.
- .
Exclusion
- Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04423484
Start Date
July 1 2020
End Date
December 30 2027
Last Update
October 3 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
Ouagadougou, Burkina Faso
2
CHU de Treichville à ABIDJAN
Abidjan, Abidjan Autonomous District, Côte d’Ivoire
3
CUK (Cliniques Universitaires de Kinshasa)
Kinshasa, Democratic Republic of the Congo, BP 12 KIN XI
4
Cliniques Universitaires de Lubumbashi (CUL)
Lubumbashi, Democratic Republic of the Congo, BP 1825